SUPPORT for Patients and Communities Reauthorization Act of 2025
March 31, 2025
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Current status: signed.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
This act secures federal funding and legal authority for national addiction prevention and treatment programs through 2030, directly impacting the availability of grants for states, tribes, and healthcare providers addressing the opioid crisis.
Potentially affected actors named in the source documents. Mention is not a position.
State and Tribal governments
They are eligible to receive grants for opioid use disorder response and prevention projects.
Healthcare providers
Prescribers of controlled substances are subject to new mandatory training requirements.
Pregnant and postpartum women
The act provides for residential treatment programs specifically tailored to their needs.
Current stage: signed.
Next step not available in the current record.
Summary
Key Facts
- Reauthorizes federal opioid use disorder prevention, treatment, and recovery programs through fiscal year 2030.
- Increases annual authorization for overdose prevention programs (Section 392A) to $505,579,000 for fiscal years 2026–2030.
- Allocates $4,250,000 annually for fiscal years 2026–2030 for prenatal and postnatal health programs.
- Expands overdose prevention strategies to include wastewater surveillance and monitoring of emerging substances.
- Updates the Fetal Alcohol Spectrum Disorder (FASD) prevention and services program to include public awareness, diagnostic research, and intervention strategies.
- Mandates training for prescribers of controlled substances.
- Establishes or continues programs for residential treatment for pregnant and postpartum women.
- Creates loan repayment programs for the substance use disorder treatment workforce.
- Includes provisions for protecting the suicide prevention lifeline from cybersecurity threats.
- Requires the development of model training programs for handling substance use disorder patient records.
Why It Matters
This act secures federal funding and legal authority for national addiction prevention and treatment programs through 2030, directly impacting the availability of grants for states, tribes, and healthcare providers addressing the opioid crisis.
Frequently Asked Questions
How long does this funding last?
Does this law change how doctors prescribe controlled substances?
What new technologies are mentioned for overdose prevention?
News Coverage
Voting Record
Total
423
Yes
366
No
57
Present
0
Not Voting
0
Abstain
0
How they voted (423)
Troy Nehls
R · yes
April McClain Delaney
D · yes
Nellie Pou
D · yes
Michael McCaul
R · yes
Eric Crawford
R · yes
Robert Bresnahan
R · yes
Laura Friedman
D · yes
James Clyburn
D · no
George Whitesides
D · yes
Jared Golden
D · yes
Delia Ramirez
D · yes
Harriet Hageman
R · yes
Henry Cuellar
D · yes
Jason Crow
D · yes
Ashley Hinson
R · yes
Brad Sherman
D · yes
Joe Courtney
D · yes
James McGovern
D · yes
Daniel Meuser
R · yes
Sarah Elfreth
D · yes
Emily Randall
D · no
Andy Biggs
R · no
Max Miller
R · yes
James Comer
R · yes
+ 399 more
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Modernization of Surveillance
The bill explicitly authorizes the use of wastewater surveillance for drug detection, marking a shift toward data-driven, non-clinical monitoring in federal policy.
Connected Entities
Sources
www.congress.gov
Analysis Score
0–100- Significance85How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz40Current news / social attention level
Publisher tools